LR

Lavaly Rani

Active Director Director DIN 10269484
DIN 10269484 First appointment Aug 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Lavaly Rani

Data last updated:

Lavaly Rani is a Director at Austinleekos Pharmaceuticals Private Limited (since 2023). The company operates in Paper. Austinleekos Pharmaceuticals Private Limited reported revenue of ₹5.7 Lakh (FY 2025).

DIN 10269484
Primary Designation Director
Industry Paper
First Appointment 07 Aug 2023
Oldest Company Age 3 yrs
Largest company Austinleekos Pharmaceuticals Private Limited · ₹5.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Aug 20232023₹5.7 Lakh (FY 2025)Active

Board colleagues of Lavaly Rani

NameDINCompanyDesignation
Sasmita Sharma10269485Austinleekos Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Austinleekos Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Lavaly Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lavaly Rani

Lavaly Rani currently holds 1 directorship: Austinleekos Pharmaceuticals Private Limited (Director, since 07 Aug 2023, revenue ₹5.7 Lakh (FY 2025)).

Lavaly Rani was first appointed on 07 Aug 2023 as Director at Austinleekos Pharmaceuticals Private Limited.

The current boards of Lavaly Rani's companies include Sasmita Sharma (Austinleekos Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available